Researchers transform stem cells found in human fat into smooth muscle cells

Researchers from the David Geffen School of Medicine and the Henry Samueli School of Engineering and Applied Science at UCLA today announced they have transformed adult stem cells taken from human adipose – or fat tissue – into smooth muscle cells, which help the normal function of a multitude of organs like the intestine, bladder and arteries. The study may help lead to the use of fat stem cells for smooth muscle tissue engineering and repair.

Reported in the July 24 online edition of the Proceedings of the National Academy of Sciences, the study is one of the first to show that stem cells derived from adipose tissue can be changed to acquire the physical and biochemical characteristics as well as the functionality of smooth muscle cells.

Smooth muscle cells are found within the human body in the walls of hollow organs like blood vessels, bladder, and intestines and contract and expand to help transport blood, urine, and waste through the body's systems.

"Fat tissue may prove a reliable source of smooth muscle cells that we can use to regenerate and repair damaged organs," said Dr. Larissa V. Rodriguez, principal investigator and assistant professor, Department of Urology, David Geffen School of Medicine at UCLA.

Rodriguez and her team first cultured the adipose-derived stem cells in a growth factor cocktail that encouraged the cells to transform into smooth muscle cells. Researchers observed the genetic expression and development of proteins, which are specific to this type of cell. So it looked like a smooth muscle cell, but would it act like one?

The next step required testing functionality to see if the cells would expand and contract like smooth muscle tissue. Rodriguez turned to associate professor of bioengineering Dr. Benjamin Wu at the UCLA Henry Samueli School of Engineering and Applied Science for help.

Wu's team developed a special device to evaluate the cells' ability to contract by tracking movement of microbeads dispersed in a collagen gel embedded with the cells. Researchers added different pharmacologic agents known to cause contraction or relaxation in smooth muscle.

"We found that the cells did indeed function just like smooth muscle," said Wu. "The new device allowed us to evaluate drug-induced changes in the physical properties of smooth muscle at the cell level – previously we've needed tissue samples to observe this phenomena."

To make sure they could reproduce the smooth muscle cells and to confirm the transformation, Rodriguez and her team cloned one of the primitive stem cells from the adipose tissue and repeated the experiments on a cloned population of cells with similar results.

"We wanted to make sure it wasn't an isolated case or particular conditions in the cell cultures that allowed us to create or select out already existing smooth muscle cells," said Rodriguez, also a member of the UCLA Stem Cell Institute. "We are surprised and pleased with the results and are excited about future applications."

Rodriguez notes the many advantages of using a patient's own fat stem cells for organ re-growth and tissue regeneration, including no need for anti-rejection medications. In patients with a diseased or absent organ, who cannot use their own organ tissue for regeneration, adipose stem cells offer an alternative.

Smooth muscle cells have also been produced from stem cells found in the brain and bone marrow, but acquiring stem cells from adipose tissue is much easier and most patients have adipose tissue readily available, according to Rodriguez.

The next step, she adds, involves identifying and developing the growth factors that will induce transformation of cells more quickly. She is also starting to use smooth muscle cells for tissue engineering in the urinary tract, including the urethra.

Source: University of California - Los Angeles

Related stories:

A fine balance
Once a toddler has mastered the art of walking, it seems to come naturally for the rest of her life. But walking and running require a high degree of coordination between the left and right sides of the body. Now researchers at the Salk Institute for Biological Studies have shown how a class of spinal cord neurons, known as V3 neurons, makes sure that one side of the body doesn't get ahead of the other.
High blood pressure takes big toll on small filtering units of the kidney
Take a kidney out of the body and it still knows how to filter toxins from the blood. But all bets are off in the face of high blood pressure.
Protein identified that plays role in blood flow
For years, researchers have known that high blood pressure causes blood vessels to contract and low blood pressure causes blood vessels to relax. Until recently, however, researchers did not have the tools to determine the exact proteins responsible for this phenomenon.
Better understanding of blood vessel constrictor needed to harness its power for patients
To harness endothelin-1's power to constrict blood vessels and help patients manage high blood pressure or heart failure, scientists must learn more about how endothelin functions naturally and in disease states, says a Medical College of Georgia researcher.
Cutting calories could limit muscle wasting in later years
Chemical concoctions can smooth over wrinkles and hide those pesky grays, but what about the signs of aging that aren't so easy to fix, such as losing muscle mass? Cutting calories early could help, say University of Florida researchers who studied the phenomenon in rats.
Trapping white blood cells proves novel strategy against chronic viral infections
Seeing disease-fighting white blood cells vanish from the blood usually signals a weakened immune system. But preventing white blood cells' circulation by trapping them in the lymph nodes can help mice get rid of a chronic viral infection, researchers at Yerkes National Primate Research Center and the Emory Vaccine Center have found.
Gene directs stem cells to build the heart
Researchers have shown that they can put mouse embryonic stem cells to work building the heart, potentially moving medical science a significant step closer to a new generation of heart disease treatments that use human stem cells.
Study in Circulation provides detail on how low blood flow promotes vascular disease
Better understanding of signaling pathway to lead to new therapies
Researchers have found the first direct proof that a key protein drives the clogging of arteries in two ways, and that lowering levels of it opens them up, according to study results published in the June edition of the journal Circulation. The work establishes cyclophilin A as an exciting target in the design of drugs against atherosclerosis, the number one cause of heart attacks and strokes, which occur when vessels become completely blocked. While the study was in mice, higher levels of the study protein have also been found in the blood of human patients with diseased blood vessels.

News discussion:

Medicine & Health news